Cn /En

News Center

——

Company news

Industry news

In vivo tumor experimental platform of InnoModels Biotechnology: Detailed explanation of features and advantages

Author:

InnoModels

Release time:

2024-07-29

In the vast field of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the field of cancer research and treatment with its innovative in vivo tumor experimental platform. With its unique technical advantages and comprehensive service system, this platform provides researchers with unprecedented experimental conditions and tools, greatly promoting the progress of cancer medicine.
1. Advanced technology, simulated reality
The core advantage of the innovative in vivo tumor experimental platform is that it can highly simulate the tumor environment in the human body. The platform not only covers tumor models of multiple cancer types (such as breast cancer, lung cancer, gastrointestinal tumors, etc.), but also simulates complex physiological factors such as the immune system and blood supply to make experimental results closer to clinical reality. This highly simulated experimental environment provides researchers with a more accurate platform to evaluate drug effects and treatment options.
2. Diverse models and rich choices
The Innovation Biotechnology platform has a large tumor cell line library, covering more than 400 different tumor cell lines, covering a wide range of cancer types and subtypes. This diverse model selection allows researchers to choose the most suitable model for experiments based on their own research needs. Whether it is basic scientific research or preclinical drug evaluation, this platform can provide strong support.
3. Technological innovation to improve efficiency
Based on the team’s rich practical experience in PDX (human tumor xenograft) model modeling and experiments, InnoModels Biotechnology has successfully developed the second-generation iPDX model platform. This innovative technology not only greatly improves the modeling success rate and experimental stability, but also more completely retains the heterogeneity and genomic information of tumor tissues, making the consistency between drug efficacy response and clinical clinical results more than 90%. In addition, the iPDX model platform also has performance close to that of tumor cell line models, and can be used for large-scale experiments with early algebraic models, thus improving research efficiency and data reliability.

4. Strict quality control and reliable results
InnoModels Biotechnology is well aware of the importance of quality control for experimental results, so it has established a strict quality control system. During the modeling process, the platform ensures the accuracy and reliability of the model through multiple methods such as pathogenic microorganism detection, STR detection, and pathology detection. At the same time, the platform also maintains thorough and traceable experimental records to meet the needs of reporting and documentation standards. These measures provide researchers with strong data support and ensure the accuracy and credibility of experimental results.
5. Comprehensive services and support for personalization
The In Vivo Tumor Experimental Platform not only provides advanced experimental technologies and tools, but is also committed to providing comprehensive service support. The platform focuses on the fields of tumor and tumor immunopharmacodynamics CRO services, translational medicine research services and personalized medicine, and provides a new generation of experimental animal models that are close to clinical practice for new drug R&D companies, translational medicine researchers and tumor patients. In addition, the platform supports personalized treatment studies, allowing researchers to conduct experiments using patient tumor samples to better understand how different patients respond to specific treatment regimens.

6. Looking to the future and continuing to innovate
InnoModels Biotechnology is well aware that in the rapidly developing field of biomedical research, continuous innovation is the key to maintaining competitiveness. Therefore, the company plans to continuously expand model types, optimize experimental processes, and combine advanced technical means to provide researchers with more comprehensive and efficient services. In the future, InnoModels Biotechnology will continue to be committed to improving the technical level of in vivo tumor experimental platforms to respond to changing scientific research needs and promote the further development of cancer medicine.
To sum up, with its advanced technology, rich model selection, strict quality control and comprehensive service support, the in vivo tumor experimental platform of InnoModels Biotechnology has demonstrated strong competitiveness and broad development in the field of cancer research and treatment. prospect. With the continuous advancement of technology and the continuous optimization of services, this platform will surely bring breakthrough research results and clinical application value to more researchers.

What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company

InnoModels Biotechnology ELISpot platform: a precise, efficient and multi-functional immune research tool

What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company

InnoModels Biotechnology ELISpot platform: a precise, efficient and multi-functional immune research tool

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License